Decapeptide-12 (Topical)
Decapeptide-12 is a research peptide with the sequence Tyr-Arg-Ser-Ala-Asp-Gly-Tyr-Gln-Gly-Leu, designed to inhibit tyrosinase and to investigate the regulation of melanogenic enzymes in vitro.
Decapeptide-12 is a research peptide with the sequence Tyr-Arg-Ser-Ala-Asp-Gly-Tyr-Gln-Gly-Leu, designed to inhibit tyrosinase and to investigate the regulation of melanogenic enzymes in vitro.
Browse nearby entries from the full catalog, starting with Topical Peptides.
Start with adjacent compounds, or send one straight to the assistant for a comparison prompt.
Ask AssistantDecapeptide-12 is a research peptide with the sequence Tyr-Arg-Ser-Ala-Asp-Gly-Tyr-Gln-Gly-Leu, designed to inhibit tyrosinase and to investigate the regulation of melanogenic enzymes in vitro. Preclinical models show its ability to modulate the activity of melanocytes as well as the gene expression involved in pigment-related signaling pathways. Decapeptide-12 serves as a model for research on peptide-mediated enzyme inhibition and control of melanogenesis.
Decapeptide-12 is a defined oligopeptide that is studied under laboratory conditions for its interaction with tyrosinase, a copper-dependent oxidase involved in phenolic oxidation and pigment biosynthesis pathways. In research models, this peptide is used as a biochemical tool to study enzyme-substrate interactions, the modulation of oxidation kinetics, and upstream regulatory steps related to pigment-related biochemical cascades.
Jump from this product into the newest URLs, recent updates, and grouped hubs.
Short-acting GHRH analog + GHSR agonist in one vial for studying pituitary axis coordination.
Synthetic fraction of the protein thymosin beta-4, used to investigate actin polymerization and cell migration in recovery contexts.
5-amino-1MQ is a small-molecule research compound that acts as a selective nicotinamide-N-methyltransferase (NNMT) inhibitor.
Acetyl Hexapeptide-3 (Argireline) is a hexapeptide analogue of SNAP-25 (Ac-Glu-Glu-Met-Gln-Arg-Arg-NHâ‚‚), developed to modulate vesicle docking and the release of catecholamines by inhibiting SNARE complex formation.
The definitive guide to peptide legality — covering BPC-157, TB-500, and other research peptides. What's legal, what's restricted, and what's changing in 2025-2026.
Comprehensive guide to BPC-157 dosing — injection, oral, and nasal protocols. How to reconstitute, calculate doses, and structure your cycle based on commonly reported approaches.
Supporting documents typically expected alongside the product profile.
This page is compiled from publicly available research material and normalized for browsing inside the catalog.